Boston Scientific (BSX) Settles Three Patent Disputes with Johnson & Johnson (JNJ); to Pay $1.725B to JNJ
Tweet Send to a Friend
Boston Scientific Corporation (NYSE: BSX) today announced the settlement of three patent disputes with Johnson & Johnson (NYSE: JNJ) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


